Plus500 does not provide its products and services to residents of United States.

Plus500 does not provide its products and services to residents of United States.

72% of retail CFD accounts lose money.

Menu

Editas Medicine EDIT

High: Low:

Editas Medicine, Inc. Genome editing company that focuses on genomic medicine. Based in Cambridge, MA, U.S. Yahoo! Finance

Traders' Sentiments

% Buyers % Sellers

Info

Editas Medicine, Inc. Genome editing company that focuses on genomic medicine. Based in Cambridge, MA, U.S. Yahoo! Finance

Spread 0.18 Spread (%) 0.99%
Overnight funding - Buy -0.04416% Overnight funding - Sell -0.04368%
Initial margin 50.00% Maintenance margin 25.00%
Leverage 1:2 Expires daily No

Related Instruments

Name Sell Sell button / Change  Buy     Change Change Change Change Change Change
{{item.Name}} {{item.SellPrice}} Sell Buy {{item.ChangePercentText}} Trade

Plus500 News & Market Insights

Tech Stocks Rally Following Fed Chair Comments
Plus500
Jan 12 2022

Tech Stocks Rally Following Fed Chair Comments

Following Jerome Powell’s comments indicating that the Fed would move to rein in inflation while avoiding much-feared drastic steps this year, tech stocks jumped, thus boosting several key Indices.

Read More →
What’s Behind Tech Stocks’ Rally?
Plus500
Dec 08 2021

What’s Behind Tech Stocks’ Rally?

Key Indices shot up on Tuesday, led by semiconductor stocks, and Nvidia in particular. How long will this momentum last?

Read More →
How Is The Omicron Strain Expected To Impact Markets?
Pinchas Cohen
Nov 29 2021

How Is The Omicron Strain Expected To Impact Markets?

U.S. equity contracts and European shares are on the rise with oil, rebounding from Friday’s steep decline due to fears of a new virus variant. There are reports that this strain’s symptoms are relatively mild, but the WHO warns of “severe consequences.”

Read More →

Why Plus500?

Understandable Platform

Competitive Spreads

Authorised and Regulated

24/7 Online Support

Need Help?
24/7 Support